Research & Development

久草在线新免费观看A片日本AV不卡在线观看不卡的无码高清的av尾盘:关注财报与联储政策 美股小幅攀升


  “都是些不知羞的!”   “我想要一種可以射的遠,而且殺傷力大的東西。”久草在线新免费观看A片   “真的,他又不知道我喜歡吃魚膾,去病向來大大咧咧的,更不會在意這些事。也不會告訴雲瑯。”日本AV不卡在线观看   “長秋,冒煙的地方是著山火了嗎?”   丑庸長得不好看,還胖,然而,她卻是一個聰明人,卓姬當初說她傻,其實是沒有看到丑庸的另一面。不卡的无码高清的av   劉婆愣了一下道︰“沒有?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo